summary: This small uncontrolled study looked at 13 people with worsening moderately severe relapsing remitting and secondary progressive MS which was not responsive to conventional treatments. It found that cyclophosphamide was safe and of some benefit in stabilising disease progression.

authors: Gladstone DE, Zamkoff KW, Krupp L, Peyster R, Sibony P, Christodoulou C, Locher E, Coyle PK.

source: Arch Neurol. 2006 Oct;63(10):1388-93. Epub 2006 Aug 14.

weblink: click here

category: Clinical Trials and Therapeutics

related research news: click here

glossary: